Bristol-Myers Squibb: Christopher Boerner
Bristol-Myers Squibb has promoted Christopher Boerner from within the company to take the position of executive vice president and chief commercial officer.
Boerner takes on the roles immediately, after having worked as head of international markets for the last year. He has been with BMS for close to four years. Prior to his position at BMS, he held various commercial roles at Seattle Genetics and Genentech.
“I’m very excited to lead such a talented and diverse commercial team globally. Along with my commercial colleagues, I look forward to continuing to help BMS deliver on our mission of bringing transformational medicines to patients,” said Boerner.
Explaining the decision to elevate Boerner to a new position, CEO Giovanni Carforio said: “Chris brings a deep knowledge of specialty care markets, a clear focus on innovation, and a proven track record of successful execution. Since joining BMS, he has successfully led our commercial organization across the US and international markets”.
